A major advance in cancer investigation is occurring with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently disabled in several types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research